Captopril in severe treatment-resistant hypertension
- 1 May 1980
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 99 (5), 579-585
- https://doi.org/10.1016/0002-8703(80)90730-9
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis.Hypertension, 1979
- Converting enzyme inhibition in essential hypertension: the hypotensive response does not reflect only reduced angiotensin II formation.Hypertension, 1979
- Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive PatientsAnnals of Internal Medicine, 1979
- Converting enzyme inhibition with an orally active compound in hypertensive man.Hypertension, 1978
- Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patientsProgress in Cardiovascular Diseases, 1978
- Primary hypertension refractory to triple drug treatment: a study on central and peripheral hemodynamics.Circulation, 1978
- Proposed Mechanisms of Propranolol's Antihypertensive Effect in Essential HypertensionNew England Journal of Medicine, 1976
- The Difficult HypertensiveDrugs, 1976
- Dependence of Arterial Pressure on Intravascular Volume in Treated Hypertensive PatientsNew England Journal of Medicine, 1972
- Treatment of Essential Hypertension with Combined Vasodilation and Beta-Adrenergic BlockadeNew England Journal of Medicine, 1972